Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma

[1]  T. Pawlik,et al.  Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis , 2020, Journal of Gastrointestinal Surgery.

[2]  Xiaofan Ding,et al.  Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas. , 2019, Gastroenterology.

[3]  Peter Schirmacher,et al.  The 2019 WHO classification of tumours of the digestive system , 2019, Histopathology.

[4]  T. Pawlik,et al.  Outcomes of Patients with Scirrhous Hepatocellular Carcinoma: Insights from the National Cancer Database , 2019, Journal of Gastrointestinal Surgery.

[5]  Y. Kanai,et al.  Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features. , 2019, Human pathology.

[6]  C. Li,et al.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China , 2019, JAMA surgery.

[7]  Y. Jeng,et al.  Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma , 2019, Hepatology.

[8]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[9]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[10]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[11]  Alan D. Lopez,et al.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level , 2017, JAMA oncology.

[12]  M. Ho,et al.  Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. , 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

[13]  S. Imbeaud,et al.  Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. , 2017, Journal of hepatology.

[14]  Ding‐Shinn Chen,et al.  Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma , 2017, The American Journal of Gastroenterology.

[15]  M. Kudo,et al.  Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update , 2017, Hepatology International.

[16]  Kui Wang,et al.  Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[17]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Kakar,et al.  Hepatocellular Carcinoma: Histologic Subtypes. , 2013, Surgical pathology clinics.

[19]  S. Kakar,et al.  Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma , 2013, Modern Pathology.

[20]  Young Bae Kim,et al.  A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma‐like gene expression trait and epithelial‐mesenchymal transition , 2012, Hepatology.

[21]  M. Choi,et al.  Clinicopathologic Characteristics and Long-Term Prognosis of Scirrhous Hepatocellular Carcinoma , 2012, Digestive Diseases and Sciences.

[22]  Masakazu Yamamoto,et al.  Specific characteristics of scirrhous hepatocellular carcinoma. , 2009, Hepato-gastroenterology.

[23]  M. Kojiro,et al.  Clinicopathological study of scirrhous hepatocellular carcinoma , 2006, Journal of gastroenterology and hepatology.

[24]  S. Kawasaki,et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.

[25]  N. Chavez-Tapia,et al.  Clinical practice guidelines: Management of Hepatocellular Carcinoma , 2014 .

[26]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[27]  Won J. Lee,et al.  Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. , 2009, European journal of radiology.